Amplia Therapeutics (ATX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ATX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Amplia Therapeutics Announces Change in Substantial Holder InterestsJune 19, 2025 | msn.comHealth Check: A pancreatic cancer ‘cure’ has been elusive, but Amplia may have cracked the nutJune 17, 2025 | msn.comPATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIALJune 16, 2025 | gurufocus.comMonday's HotCopper trends: 4DS falls short, $30B bid for Santos | June 16, 2025June 16, 2025 | msn.comFavourable Signals For Amplia Therapeutics: Numerous Insiders Acquired StockJune 2, 2025 | finance.yahoo.comAmplia Therapeutics Releases 2025 Corporate Governance StatementMay 30, 2025 | tipranks.comDr Boreham’s Crucible: This pancreatic cancer tackler has faith its ‘good science will prevail’May 26, 2025 | msn.comHealth Check: Amplia shares surge on pancreatic cancer trial results; Immutep offers hopeMay 16, 2025 | msn.comASX Market Close: IT stocks lead index higher | May 15, 2025May 15, 2025 | msn.comAmplia pops 40% on liquidity surge as chemo combo proves successfulMay 15, 2025 | msn.comAmplia Therapeutics Launches US Trial for Innovative Pancreatic Cancer TreatmentApril 8, 2025 | tipranks.comAmplia Therapeutics Advances Cancer Treatment with Promising Trial Results and Strategic CollaborationsJanuary 29, 2025 | tipranks.comAmplia Therapeutics Limited (INNMF)January 4, 2025 | finance.yahoo.comIndependent Non-Executive Director of Amplia Therapeutics Robert Peach Buys 25% More SharesDecember 24, 2024 | uk.finance.yahoo.comAmplia Therapeutics Announces Director’s Share AcquisitionDecember 21, 2024 | markets.businessinsider.comAmplia Therapeutics Announces Change in Director’s InterestDecember 20, 2024 | msn.comAmplia Therapeutics Director Increases Stake, Boosting Investor InterestDecember 20, 2024 | msn.comAmplia Therapeutics Shows Promising Data in Cancer TrialDecember 11, 2024 | markets.businessinsider.comAmplia Therapeutics Reports Increased Losses Amid Revenue DeclineNovember 26, 2024 | tipranks.comAmplia Therapeutics Partners with Next&Bio for Cancer ResearchNovember 13, 2024 | markets.businessinsider.comAmplia Therapeutics Shareholding Update by Platinum AssetNovember 8, 2024 | markets.businessinsider.comAmplia Therapeutics Completes $13M Share AllotmentNovember 8, 2024 | markets.businessinsider.comAmplia Therapeutics to Issue New Securities on ASXNovember 6, 2024 | markets.businessinsider.comAmplia Therapeutics Lists New Shares on ASXNovember 5, 2024 | tipranks.comAmplia Therapeutics Announces $4.9M Capital Raising PlanNovember 2, 2024 | markets.businessinsider.comAmplia Therapeutics Completes Successful Capital RaiseNovember 1, 2024 | markets.businessinsider.comAmplia Therapeutics Boosts Stock Confidence with Underwritten OfferNovember 1, 2024 | markets.businessinsider.comAmplia Therapeutics Announces New Share and Option OffersOctober 31, 2024 | markets.businessinsider.comAmplia Therapeutics Announces New Securities IssuanceOctober 31, 2024 | markets.businessinsider.comAmplia Therapeutics Stock Down 10.0% But Insiders Still In AU$763k ProfitOctober 31, 2024 | finance.yahoo.comAmplia Therapeutics Announces Capital Raising InitiativeOctober 30, 2024 | markets.businessinsider.comAmplia Therapeutics Announces Major Securities OfferOctober 30, 2024 | markets.businessinsider.comAmplia Therapeutics Pauses Trading Amid Capital RaisingOctober 29, 2024 | markets.businessinsider.comAmplia CEO co-recipient of 2024 Prime Minister’s Prize for InnovationOctober 9, 2024 | msn.comAmplia Therapeutics’ Narmafotinib Gets Fast-track Designation from FDASeptember 26, 2024 | msn.comAmplia Therapeutics Ltd: FDA Fast Track Designation For Narmafotinib In Advanced Pancreatic CancerSeptember 20, 2024 | finanznachrichten.deMoneyTalks: Pengana’s James McDonald reveals his top three ASX biotechsSeptember 19, 2024 | msn.comAmplia Therapeutics Ltd INNMFAugust 15, 2024 | morningstar.comM5 Pharma & Biotech Stocks on the move in JulyAugust 12, 2024 | msn.comASX Health Stocks: Amplia sees new success in pancreatic cancer trialAugust 6, 2024 | msn.comAllan Moss Buys 40% More Amplia Therapeutics SharesMay 23, 2024 | finance.yahoo.comASX Health Stocks: Argenica’s traumatic brain injury drug works well in animal modelMay 15, 2024 | msn.comAmplia Therapeutics moves to next phase of pancreatic cancer treatment trialFebruary 13, 2024 | finance.yahoo.comFDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN USJanuary 18, 2024 | finance.yahoo.comGDTC CytoMed Therapeutics LimitedAugust 22, 2023 | seekingalpha.comAMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic CancerMay 29, 2023 | finance.yahoo.comAmplia secures funding to assess AMP945 topical applicationsMay 21, 2023 | proactiveinvestors.com.auAmplia Therapeutics Ltd (ATX)May 17, 2023 | investing.comAmplia Therapeutics Limited (ATX.AX)March 10, 2023 | uk.finance.yahoo.comAmplia Therapeutics CEO outlines 2023 milestonesFebruary 27, 2023 | finance.yahoo.com Get Amplia Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATX and its competitors with MarketBeat's FREE daily newsletter. Email Address ATX Media Mentions By Week ATX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATX News Sentiment▼0.000.93▲Average Medical News Sentiment ATX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATX Articles This Week▼00▲ATX Articles Average Week Get Amplia Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TH News OBI News SCLP News HVO News ONC News COV News MDNA News SVA News APS News HBP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:ATX) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplia Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
